Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected african patients

American Journal of Tropical Medicine and Hygiene

Volumn 65, Issue 6, 2001, Pages 711-716

  Ngouesse, B ^a   Basco, L K ^a   Ringwald, P ^a   Keundjian, A ^a   Blackett, K N ^a  

^a Strat Devmt/Monit Erad/Eliminat   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; DEETHYLAMODIAQUINE; FANSIDAR;

ADULT; ARTICLE; BODY WEIGHT; BRADYCARDIA; CARDIOVASCULAR DISEASE; CLEARANCE; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; FEVER; FOLLOW UP; HUMAN; MALARIA; MALARIA FALCIPARUM; PLASMODIUM FALCIPARUM; QRS COMPLEX; QT INTERVAL; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0035683545     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2001.65.711     Document Type: Article

References (32)

1. Amodiaquine as the first-line treatment of malaria in Yaoundé Cameroon: Presumptive evidence from activity in vitro and cross-resistance patterns
2. Systematic review of amodiaquine treatment in uncomplicated malaria
3. A comparison of amodiaquine and chloroquine in the treatment therapy of falciparum malaria in Kenya
4. Atovaquone and proguanil for Plasmodium falciparum malaria
5. Surveillance de la chimiorésistance par le test de l'efficacité thérapeutique à Yaoundé 2. Efficacité de l'amodiaquine et de la sulfadoxine-pyriméthamine pour le traitement de l'accès non compliqué à Plasmodium falciparum chez les enfants âgés de plus de 5 ans et chez les adultes
6. Quinine and quinidine: A comparison of EKG effects during the treatment of malaria
7. Cardiac effects of antimalarial treatment with halofantrine
8. The pharmacokinetics and electrocardiographic effects of chloroquine in healthy subjects
9. Comparative cardiac effects of halofantrine and chloroquine plus chlorpheniramine in children with acute uncomplicated falciparum malaria
10. Adaptations of the Saker-Solomons test: Simple, reliable colorimetric field assays for chloroquine and its metabolites in urine
11. Severe and complicated malaria
12. Pharmacokinetics of sulfadoxine and pyrimethamine after Fansidar administration in man
13. The disposition of amodiaquine in Zambians and Nigerians with malaria
14. 4 acetylsulphadoxine and pyrimethamine in human plasma
15. Simultaneous determination of chloroquine, amodiaquine and their metabolites in human plasma, red blood cells, whole blood and urine by column liquid chromatography
16. Cardiac complications of halofantrine: A prospective study of 20 patients
17. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria
18. Cardiac effects of halofantrine in children suffering from acute uncomplicated falciparum malaria
19. Lack of a significant adverse cardiovascular effect of combined quinine and mefloquine therapy for uncomplicated malaria
20. Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: A double-blind, placebo-controlled trial
21. No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine
22. Effectiveness of amodiaquine, sulfadoxine-pyrimethamine, and combination of these drugs for treating chloroquine-resistant falciparum malaria in Hainan Island, China
23. A double blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria
24. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria
25. Prolongation of the QTc interval in African children treated for falciparum malaria
26. Pharmacokinetics and metabolism of amopyroquin after administration of two doses of 6 mg/kg im 24 h apart to healthy volunteers
27. Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malaria
28. Combination chemotherapy for Plasmodium falciparum malaria